Core Viewpoint - Tongyun Biotechnology (01332) has seen a significant stock price increase of over 81%, reaching a peak of 0.75 HKD, which represents an almost 900% rise from the opening price of 0.076 HKD on October 30 [1] Company Summary - Tongyun Biotechnology is a wholly-owned subsidiary of Hong Kong-listed Tongyun Biotechnology Group, established in 2020 in Lucheng District, Shanxi Province, with an investment of 370 million HKD to build the world's first large-scale production facility for Rhizoclonium algae [1] - The company has a planned annual production capacity of 20,000 tons of Rhizoclonium algae powder, with the first phase of 4,000 tons having commenced production three months ahead of schedule in March 2023, utilizing a unique acetic acid fermentation process for automated production [1] Strategic Partnership - On October 24, Tongyun Biotechnology signed a strategic cooperation agreement with a sales consortium consisting of Shenzhen Building Supply Chain Technology Co., Ltd., Henan Guozi Marketing Management Co., Ltd., and Beijing He Wan Jia Biotechnology Co., Ltd. [1] - According to the agreement, the consortium will purchase no less than 1 billion HKD worth of Rhizoclonium algae products from Tongyun Biotechnology between 2026 and the end of 2028 [1]

Core Viewpoint - Tuo Yun Bio (01332) has seen a significant stock price increase of nearly 900% since October 30, with a peak of 0.75 HKD and a current price of 0.56 HKD, driven by a strategic partnership agreement for substantial product procurement [1] Company Summary - Shanxi Tuo Yun Bio Technology Co., Ltd., a wholly-owned subsidiary of Tuo Yun Bio Group, has signed a strategic cooperation agreement with a sales consortium for the procurement of no less than 1 billion RMB worth of Rhizoclonium algae products from 2026 to 2028 [1] - The company is recognized as a key project and high-tech enterprise in Shanxi Province, having established the world's first large-scale production facility for Rhizoclonium algae with an investment of 370 million RMB [1] - The facility, located in Lucheng District, is designed to produce 20,000 tons of Rhizoclonium algae powder annually, with the first phase of 4,000 tons having commenced production three months ahead of schedule in March 2023 [1] Industry Summary - The strategic partnership highlights the growing demand for microalgae products, which are increasingly recognized for their potential in various applications, including health and nutrition [1] - The use of proprietary acetic acid fermentation technology in a closed automated production process addresses traditional challenges in the microalgae industry, such as land use and pollution [1]

Core Viewpoint - The stock of Touyun Biotechnology (01332) surged over 70% following the announcement of a strategic cooperation agreement worth at least 1 billion yuan for the procurement of its products from 2026 to 2028 [1] Company Summary - Touyun Biotechnology, a subsidiary of Hong Kong-listed Touyun Biotechnology Group, focuses on developing advanced fermentation technology to produce green food, specifically the Rhenish algae [1] - The recent strategic cooperation agreement marks a significant milestone for the commercialization of Rhenish algae, indicating the company's transition into a phase of large-scale commercial realization [1] Industry Summary - The agreement involves a sales consortium consisting of Shenzhen Building Supply Chain Technology Co., Ltd., Henan Guozi Marketing Management Co., Ltd., and Beijing He Wan Jia Biotechnology Co., Ltd., highlighting a collaborative effort in the industry [1] - The procurement agreement is set to enhance the market presence of Rhenish algae products, potentially leading to increased demand and growth within the green food sector [1]